ArticleMolecular neurobiology2022

Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson's Disease.

Daniel F Tardiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.